Metsera has filed for an initial public offering. The clinical-stage biopharmaceutical company submitted a registration statement to regulators on Friday, saying it intends to list under the ticker ...

The terms of the IPO were not disclosed in the filing. Strong equity markets, falling interest rates and hopes of a ...

It certainly was a big week — with companies having to raise more than $100 million to make the list. Biotech- and healthcare ...

A new company is making its debut with a series A sum that’s sure to make hearts race. | A new company is making its debut ...

“Jami is an industry-leading intellect and advisor to transformational healthcare companies,” said Mark Van Lith, CEO of Guggenheim Securities. “Jami is an important addition to our premier healthcare ...

After the successful development of mavacamten and the sale of MyoKardia to BMS in 2020, former executives of the biotech are ...

Kardigan, a heart health company modernizing cardiovascular drug development, launched today with a mission to develop multiple targeted treatments in parallel, bringing people with cardiovascular ...

The startup world begins 2025 on a decidedly more upbeat note than it did the previous year. The renewed optimism is in part ...

Stanton Williams has been selected to design the Fleming Centre, a state-of-the-art research and public engagement facility ...

Every Spider-Man movie has given alternative versions of our favorite web-slinging hero. It looks like Disney+ will provide ...

Dr. McClure's distinguished track record in designing and directing successful early-to-late-stage clinical trials, which include several marketed products, further demonstrates Lifordi's commitment ...

About a year ago, Tenvie President and Chief Scientific Officer Tony Estrada approached Denali CEO Ryan Watts and others in ...